Neurodegenerative diseases: from gut-brain axis to brain microbiome.
作者信息
Friedland Robert P, Haribabu Bodduluri
机构信息
Department of Neurology, University of Louisville School of Medicine, Louisville, KY, United States.
Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, United States.
出版信息
Front Aging Neurosci. 2023 May 19;15:1171955. doi: 10.3389/fnagi.2023.1171955. eCollection 2023.
Abstract
摘要
相似文献
1
Neurodegenerative diseases: from gut-brain axis to brain microbiome.
Front Aging Neurosci. 2023 May 19;15:1171955. doi: 10.3389/fnagi.2023.1171955. eCollection 2023.
2
A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
J Alzheimers Dis. 2020;73(3):849-865. doi: 10.3233/JAD-190872.
3
The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer's Disease.
CNS Neurol Disord Drug Targets. 2023;22(4):577-598. doi: 10.2174/1871527321666220417005115.
5
Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases.
Ageing Res Rev. 2022 Jun;78:101620. doi: 10.1016/j.arr.2022.101620. Epub 2022 Apr 8.
6
Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110112. doi: 10.1016/j.pnpbp.2020.110112. Epub 2020 Sep 16.
7
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.
Curr Neurol Neurosci Rep. 2017 Oct 17;17(12):94. doi: 10.1007/s11910-017-0802-6.
8
Gut microbiota and pro/prebiotics in Alzheimer's disease.
Aging (Albany NY). 2020 Mar 19;12(6):5539-5550. doi: 10.18632/aging.102930.
9
Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease.
CNS Neurol Disord Drug Targets. 2022;21(1):14-25. doi: 10.2174/1871527320666210806165751.
10
Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer's disease.
J Neuroinflammation. 2018 Jun 22;15(1):190. doi: 10.1186/s12974-018-1223-4.
引用本文的文献
1
The microbial guardians: Unveiling the role of gut microbiota in shaping neurodegenerative disease.
IBRO Neurosci Rep. 2025 May 30;19:17-37. doi: 10.1016/j.ibneur.2025.05.014. eCollection 2025 Dec.
2
The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer's and Parkinson's Diseases.
Nutrients. 2024 Jan 19;16(2):308. doi: 10.3390/nu16020308.
本文引用的文献
1
Mutant and curli-producing E. coli enhance the disease phenotype in a hSOD1-G93A mouse model of ALS.
Sci Rep. 2023 Apr 12;13(1):5945. doi: 10.1038/s41598-023-32594-5.
2
Editorial: Neurodegenerative diseases: From gut-brain axis to brain microbiome.
Front Aging Neurosci. 2022 Oct 12;14:1052805. doi: 10.3389/fnagi.2022.1052805. eCollection 2022.
3
Gut microbiome-mediated regulation of neuroinflammation.
Curr Opin Immunol. 2022 Jun;76:102177. doi: 10.1016/j.coi.2022.102177. Epub 2022 Apr 21.
4
Inflammasome activation in neurodegenerative diseases.
Essays Biochem. 2021 Dec 22;65(7):885-904. doi: 10.1042/EBC20210021.
5
Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration.
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34). doi: 10.1073/pnas.2106504118.
6
Identification of amyloidogenic proteins in the microbiomes of a rat Parkinson's disease model and wild-type rats.
Protein Sci. 2021 Sep;30(9):1854-1870. doi: 10.1002/pro.4137. Epub 2021 Jun 9.
7
Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice.
Sci Rep. 2021 Jan 12;11(1):518. doi: 10.1038/s41598-020-80063-0.
8
Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives.
Expert Opin Investig Drugs. 2020 Sep;29(9):919-933. doi: 10.1080/13543784.2020.1795127. Epub 2020 Jul 26.
9
A gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice.
Elife. 2020 Feb 11;9:e53111. doi: 10.7554/eLife.53111.
10
Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspire Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents.
PLoS Pathog. 2019 Aug 30;15(8):e1007978. doi: 10.1371/journal.ppat.1007978. eCollection 2019 Aug.
Zotero 插件